Turnstone Biologics CORP DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
Turnstone Biologics Corp. has filed a definitive proxy statement with the SEC.
Turnstone Biologics Corp. will hold its annual meeting of stockholders virtually on June 3, 2024, to elect directors and ratify the selection of Ernst & Young LLP as the company's independent registered public accounting firm.